WASHINGTON — The U.S. Defense Department is weighing a new search for immune-protein “cocktails” it hopes will protect humans against Ebola and other deadly, weapon-usable viruses.
The Pentagon two weeks ago invited scientists to submit research proposals for designing “monoclonal antibodies” that could protect against Ebola and Marburg, as well as “alphaviruses” such as Venezuelan equine encephalitis.
Pentagon planners have been turning to antibodies as a possible tool because “no easy and quick fix” for such agents has emerged from efforts to develop vaccines or traditional antiviral treatments, said Gigi Gronvall, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center.
The early-stage research now under consideration ideally would lead to single-shot treatments capable of guarding troops for months from multiple virus types, the Defense Threat Reduction Agency said in a Sept. 18 solicitation. DTRA officials welcomed researchers to propose “‘cocktails’ that may enable cross-protection against multiple species of virus.”
The emphasis on “cocktails” makes the latest DTRA proposal particularly notable, because several studies suggest that mixes of several antibodies can be particularly effective in fighting pathogens, Gronvall told Global Security Newswire in a telephone interview. Antibodies hit their targets with such specificity that a treatment with multiple immune proteins can help account for slight variations between invading microbes.
Monoclonal antibodies have been in use since the 1980s to treat cancer and immune-linked ailments such as rheumatoid arthritis, but their use against infectious pathogens has lagged, according to a DTRA-sponsored report co-authored by Gronvall on the technology’s biodefense potential.
The United States last year licensed the first inhalation anthrax treatment to use the technology, which involves creating massive quantities of a single immune “antibody.” The human body naturally generates such proteins, each of which is designed to mark a specific pathogen or toxin for elimination by other immune-system components.
One antibody cocktail grown in modified tobacco plants showed promising potency against Ebola infections specifically, according to a study published in August.
“There have been a lot of changes in the way that monoclonal antibody technologies have evolved over the last several years, and it makes monoclonal antibodies a very nice piece of their approach to medical countermeasures,” Gronvall said.
The latest DTRA Broad Agency Announcement seeks proposals for studies no longer than one year, with a cost no greater than $500 million. The filing deadline is Oct. 16.
What We're Following See More »
"An emerging theory among U.S. military investigators is that the Army Special Forces soldiers ambushed in Niger were set up by terrorists, who were tipped off in advance about a meeting in a village sympathetic to local ISIS affiliates...The group of American Green Berets and support soldiers had requested a meeting with elders of a village that was seen as supportive of the Islamic State, and they attended the meeting at around 11 a.m. local time Oct. 4...Such meetings are a routine part of the Green Beret mission, but it wasn't clear whether this meeting was part of the unit's plan."
"The long-awaited sentencing of Army Sgt. Bowe Bergdahl was delayed Monday after a legal battle erupted over the word 'but' in President Donald Trump's most recent remarks about the case. Bergdahl's defense team argued that their client could not get a fair shake from the court because Trump, during a Rose Garden appearance on Oct. 16, at first said he couldn't talk about the case and then added: 'But I think people have heard my comments in the past.'" Trump has called him a traitor and suggested he should be executed.
"The Trump administration is coming under increased pressure from Congress to kill a landmark deal between Boeing and an Iranian airline known for engaging in terrorism over concerns the Western airline company would enable Tehran's transfer of militant fighters across the region, according to multiple sources, who told the Washington Free Beacon the administration is likely to nix the multi-billion dollar deal. The Obama administration's nuclear agreement with Iran paved the way for U.S. aerospace corporation Boeing to ink a deal with Iran's state-controlled airline, Iran Air, which was recently caught using its commercial planes to ferry Iranian militants to regional hotspots."
"Tony Podesta and the Podesta Group are now the subjects of a federal investigation being led by Special Counsel Robert Mueller, three sources with knowledge of the matter told NBC News. The probe of Podesta and his Democratic-leaning lobbying firm grew out of Mueller's inquiry into the finances of former Trump campaign chairman Paul Manafort."